Thrombolytic treatment for acute myocardial infarction provides clear clinical benefits despite recognized limitations, prompting ongoing research to improve patient outcomes.
This review summarizes current practice and ongoing research to improve outcomes in patients with acute myocardial infarction, including the benefits and limitations of thrombolytic treatment.
Absolute Event Rate: 0% vs 0%
A H Gershlick, R S More Coronary artery occlusion is responsible for 180 000 admissions to hospital each year in the United Kingdom. 2] The benefits of thrombolytic treatment have been shown clearly in clinical trials, but there are limitations. We review current practice and the research that is currently under way to improve outcome in patients who have had acute myocardial infarction.
Gershlick et al. (Sat,) reported a other. Thrombolytic treatment for acute myocardial infarction provides clear clinical benefits despite recognized limitations, prompting ongoing research to improve patient outcomes.